Cargando…
Biomarkers in the Pathogenesis, Diagnosis, and Treatment of Systemic Sclerosis
Systemic sclerosis (SSc) is a complex autoimmune disease characterized by vascular damage, vasoinstability, and decreased perfusion with ischemia, inflammation, and exuberant fibrosis of the skin and internal organs. Biomarkers are analytic indicators of the biological and disease processes within a...
Autores principales: | Muruganandam, Maheswari, Ariza-Hutchinson, Angie, Patel, Rosemina A, Sibbitt, Wilmer L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590076/ https://www.ncbi.nlm.nih.gov/pubmed/37868834 http://dx.doi.org/10.2147/JIR.S379815 |
Ejemplares similares
-
Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment
por: Affandi, Alsya J., et al.
Publicado: (2015) -
White Matter Correlates of Neuropsychological Dysfunction in Systemic Lupus Erythematosus
por: Jung, Rex E., et al.
Publicado: (2012) -
Biomarkers inform clinical trials and pathogenesis in systemic sclerosis
por: Lafyatis, R
Publicado: (2010) -
Aortic Atherosclerosis in Systemic Lupus Erythematosus
por: Roldan, Paola C, et al.
Publicado: (2014) -
Hypoxia. Hypoxia in the pathogenesis of systemic sclerosis
por: Beyer, Christian, et al.
Publicado: (2009)